Daniel Kontoh-Boateng | Investor Relations |
Lisa Ricciardi | President and Chief Executive Officer |
Jim O'Brien | Chief Financial Officer |
Tony Caggiano | Chief Medical Officer and Head of R&D |
Mayank Mamtani | B. Riley Securities |
00:04 Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2021 Earnings Conference Call. My name is Olivia and I will be your conference operator today. This call is being recorded. 00:18 I would now like to turn the presentation over to your speaker host for today's call, Mr. Daniel Kontoh-Boateng, Investor Relations for Cognition Therapeutics.